Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Brian Thomas Hertzog who wrote (797)	7/6/1998 11:18:00 AM
From: Robert Knight	Read Replies (1) \| Respond to of 1510

I believe a few IB's were aware of the PR that IMNR was going to release pre-conference and started selling into the public's "anticipation". Though the news is quite good, they deduced that it was not earth shattering and started to dump. How else could you explain Lehman's fervent selling BEFORE any news came out of Geneva? I also believe the shorts saw this and added to the downward pressure. The MM's need volitility to make their money and they seized the moment. Though IMNR has never been so close to actually having a substantial product come to market, the recent momentum has been to the downside created by the traders and shorts. This momentum was started BEFORE the conference. Someone knew something. Look at this AHM guy. Telling people the stock is going to rock, ect..., yet he was short on 6/25 before his first bullish post. I am hoping that IMNR's IR will provide us longs with a little surprise of our own. I am also hoping that the Wall St. analysts will disemenate the news from the conference and see the real value that I believe IMNR deserves at this time. IBT is the new tack in the fight against HIV and IMO people are going to start to realize that IMNR is going to be a major player. JMHO..... Currently, DEAN high bid @ 9/16, NITE on the offer at 5/8's Robert